Analyst Price Target is GBX 0
This price target is based on 0 analysts offering 12 month price targets for Scapa Group in the last 3 months. The average price target is GBX 0, with a high forecast of GBX 0 and a low forecast of £100,000. The average price target represents a NaN upside from the last price of GBX 0.
Current Consensus is
N/A
The current consensus among 0 contributing investment analysts is to n/a stock in Scapa Group. This N/A consensus rating has held steady for over two years.
Scapa Group plc, together with its subsidiaries, manufactures and sells bonding products and adhesive components for applications in the healthcare and industrial markets in Europe, North America, and Asia. The company offers wound dressings and topical skin care solutions; first aid and personal care products; skin adhesives and medical-grade substrates; and customize adhesive formulations for various applications. It also provides adhesive systems for automotive wire harness systems; cable tapes and jointing components for applications in power, sub-sea, control, data, and fiber optic cables; self-adhesive tape solutions for the building and construction market; specialty products, such as technical adhesive tapes, and films and foams; and consumer tapes. In addition, the company offers PVC tapes under the Barnier brand name, polyethylene tapes under the Polyflex name, and hockey tapes under the Renfrew brand name. Scapa Group plc was founded in 1927 and is headquartered in Ashton-Under-Lyne, the United Kingdom. As of April 15, 2021, Scapa Group plc operates as a subsidiary of Schweitzer-Mauduit International, Inc.
Read More
